ID

37633

Descripción

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran; ODM derived from: https://clinicaltrials.gov/show/NCT02331602

Link

https://clinicaltrials.gov/show/NCT02331602

Palabras clave

Versiones (1)
  1. 12/8/19 12/8/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

12 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Atrial Fibrillation NCT02331602

Inglés

Eligibility Atrial Fibrillation NCT02331602

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
non-valvular atrial fibrillation
Descripción

Atrial Fibrillation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004238
a chads2-vasc score of 1 or more
Descripción

CHA2DS2-VASc score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4049268
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindication for rivaroxaban or dabigatran
Descripción

Medical contraindication Rivaroxaban | Medical contraindication Dabigatran

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1739768
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C2348066
stroke or systemic embolism, acute coronary syndromes or peripheral artery disease within 6 months before enrollment
Descripción

Cerebrovascular accident | EMBOLISM, SYSTEMIC ARTERIAL | Acute Coronary Syndrome | Peripheral Arterial Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0149876
UMLS CUI [3]
C0948089
UMLS CUI [4]
C1704436
acute heart failure
Descripción

Heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018801
severe chronic renal failure (creatinine clearance < 30ml/min.)
Descripción

Chronic Kidney Failure Severe | Creatinine clearance measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0022661
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0373595
receiving dual antiplatelet therapy
Descripción

Antiplatelet therapy Dual

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1096021
UMLS CUI [1,2]
C0205173
patients with a body weight of 50kg or less
Descripción

Body Weight

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005910
uncontrolled hypertension
Descripción

Uncontrolled hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1868885
active malignancy, collagen disease, or infectious disease
Descripción

Malignant Neoplasms | Collagen Disease | Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0009326
UMLS CUI [3]
C0009450
patients undergoing surgery within 6 months before enrollment
Descripción

Operative Surgical Procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543467
patients who are planned to undergoing catheter ablation for atrial fibrillation
Descripción

Catheter ablation for atrial fibrillation Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2702800
UMLS CUI [1,2]
C1301732
patients who are not allowed to participate in the trial by judgement of the treating physician
Descripción

Study Subject Participation Status Rejected Physician Decision

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548437
UMLS CUI [1,3]
C1709536
Volver a la parte superior de la página

Similar models

Eligibility Atrial Fibrillation NCT02331602

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Atrial Fibrillation
Item
non-valvular atrial fibrillation
boolean
C0004238 (UMLS CUI [1])
CHA2DS2-VASc score
Item
a chads2-vasc score of 1 or more
boolean
C4049268 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Rivaroxaban | Medical contraindication Dabigatran
Item
contraindication for rivaroxaban or dabigatran
boolean
C1301624 (UMLS CUI [1,1])
C1739768 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C2348066 (UMLS CUI [2,2])
Cerebrovascular accident | EMBOLISM, SYSTEMIC ARTERIAL | Acute Coronary Syndrome | Peripheral Arterial Disease
Item
stroke or systemic embolism, acute coronary syndromes or peripheral artery disease within 6 months before enrollment
boolean
C0038454 (UMLS CUI [1])
C0149876 (UMLS CUI [2])
C0948089 (UMLS CUI [3])
C1704436 (UMLS CUI [4])
Heart failure
Item
acute heart failure
boolean
C0018801 (UMLS CUI [1])
Chronic Kidney Failure Severe | Creatinine clearance measurement
Item
severe chronic renal failure (creatinine clearance < 30ml/min.)
boolean
C0022661 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
Antiplatelet therapy Dual
Item
receiving dual antiplatelet therapy
boolean
C1096021 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
Body Weight
Item
patients with a body weight of 50kg or less
boolean
C0005910 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Malignant Neoplasms | Collagen Disease | Communicable Disease
Item
active malignancy, collagen disease, or infectious disease
boolean
C0006826 (UMLS CUI [1])
C0009326 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
Operative Surgical Procedure
Item
patients undergoing surgery within 6 months before enrollment
boolean
C0543467 (UMLS CUI [1])
Catheter ablation for atrial fibrillation Planned
Item
patients who are planned to undergoing catheter ablation for atrial fibrillation
boolean
C2702800 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Study Subject Participation Status Rejected Physician Decision
Item
patients who are not allowed to participate in the trial by judgement of the treating physician
boolean
C2348568 (UMLS CUI [1,1])
C1548437 (UMLS CUI [1,2])
C1709536 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial